Navigation Links
Researchers Use Gene Therapy to Restore Eyesight in Blind Mice

A new study has used gene therapy to bring back eyesight in mice that had a form of hereditary blindness.

The finding may have an impact on many of the common blinding diseases in humans, researchers now state.

The study was conducted by a team of researchers led by John J. Alexander at the University of Florida.

As part of the study, researchers conducted experiments on mice that had a hereditary blindness called achromatopsia.

This disease affects eyesight by putting cone photoreceptors in the retina out of action. The disease not only causes almost complete color blindness, but also very poor central vision.

As a part of the research the researchers used a harmless virus to provide corrective genes to mice with a genetic impairment that blocks their vision.

Researchers measured the electrical activity in the retinas of mice for two months after the administering the gene therapy injection into the subretinal space of the rodents.

Scientists found that 19 out of the 21 treated eyes responded to therapy positively, and 17 of those 19 had electrical readings from their retinas much similar to those taken in normal mice.

Tests in mice between 6 and 7 months old showed that 18 of the 21 treated eyes responded in a normal manner.

Also, a smaller group of treated mice were assessed with a test similar to doctors eye test. Researchers found that the mice had normal visual perception with their treated eyes.

"People can talk and tell us what they see," Nature quoted Alexander, as saying.

"Animals are much more difficult. What makes this test so fantastic is that it involves an animals natural response, and the results tell us that the animals brains are involved in the process, that they are actually seeing something," he added.

The research shows that it is possible to focus and save cone cells which are th e vital for visual sharpness and color vision in people.

According to Richard Weleber, a professor of molecular and medical genetics at Oregon Health & Science University who was not involved in the research, the study this cone-targeted gene therapy is first on its kind and has great implications for a number of degenerative diseases.

"This is the first to my knowledge of a cone-targeted gene therapy that restores function in an animal model where cones are the primary defect," Weleber said.

"This validates the concept that it is possible to deliver a gene therapy targeting the cone system, and that is incredibly important for a number of degenerative diseases," he added.

The findings of the study were published in the online edition of Nature Medicine.


'"/>




Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... January 24, 2017 , ... In comments ... Research Institute (PCORI) for developing a data access and sharing policy. The nation’s ... data sharing plan as part of award applications, and earmarking specified amounts of ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... introduces more changes during the Annual Enrollment Period (AEP) and the Open Enrollment ... looking for health insurance coverage. Mainly, people are witnessing higher deductibles, rising premiums, ...
(Date:1/24/2017)... ... January 24, 2017 , ... PeroxyChem Food and ... Control Equipment (PACE), at the International Production and Processing Expo (IPPE) in Atlanta, ... the new technology that is used in poultry processing facilities to provide constant, ...
(Date:1/24/2017)... , ... January 24, 2017 , ... ... “Lacto-Freedom” was recently accepted as a Registered Trademark by the United States Patent ... using a similar name which could confuse consumers into thinking that other products ...
(Date:1/24/2017)... Estates, CA (PRWEB) , ... January 24, 2017 , ... ... at studies, work, athletics or even in relationships. Course offered by Dr. Carol ... is necessary due to limited seating and the many hands-on experiences. , ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... , Jan. 24, 2017   Intrexon Corporation ... and industrialization of biology to improve the quality of life ... entered into a definitive agreement to acquire GenVec, Inc ... pioneer in the development of AdenoVerse™ gene delivery technology.  ... expertise in adenoviral vectors and cGMP drug product manufacturing to ...
(Date:1/24/2017)... 24, 2017   Keneric Healthcare , a ... effective patient care products, today announced their partnership ... the reach of both companies by leveraging their ... Angelini Pharma Inc . ... include Keneric Healthcare,s RTD™ Wound Dressing (antibacterial/antifungal).  RTD™ ...
(Date:1/24/2017)... 2017 Stock-Callers.com today has issued research ... ZTS ), Mallinckrodt PLC (NYSE: MNK ), ... Inc. (NYSE: DPLO ). According to pharmaceutical manufacturer ... 2017 for the Generic Drugs industry, including a possible reduction ... current growth, and a speedier FDA approval process that could ...
Breaking Medicine Technology: